We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Sponsor content
866 result(s) found, displaying 391 to 400
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for IRINOTECAN ACCORD irinotecan hydrochloride trihydrate 300 mg/15 mL concentrated injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for IRINOTECAN INTAS irinotecan hydrochloride trihydrate 500 mg/25 mL concentrated injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for IRINOTECAN INTAS irinotecan hydrochloride trihydrate 300 mg/15 mL concentrated injection vial.
-
Prescription medicine registrationActive ingredients: sitagliptin phosphate.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for TOPOTECAN ACCORD topotecan (as hydrochloride) 4 mg/4 mL concentrated injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for TOPOTECAN ACCORD topotecan (as hydrochloride) 1 mg/1 mL concentrated injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for TOPOTECAN INTAS topotecan (as hydrochloride) 1 mg/1 mL concentrated injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for TOPOTECAN INTAS topotecan (as hydrochloride) 4 mg/4 mL concentrated injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for MONTELUKAST VIATRIS montelukast 10 mg (as sodium) film-coated tablet blister pack.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for MONTELUKAST VIATRIS montelukast 5 mg (as sodium) chewable tablet blister pack.